ARID2 (AT-Rich Interaction Domain 2)

Migration, Crosslink

📖

ARID2 (AT-Rich Interaction Domain 2)

active

wiki page Created: 2026-04-02T07:19:17 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-arid2

📖 Wiki Page

gene1031 wordssynced 2026-04-02

ARID2 (AT-Rich Interaction Domain 2)

<div class="infobox infobox-gene">
<h3>ARID2</h3>
<table> [@mashtalir2018]
<tr><td><strong>Full Name</strong></td><td>AT-Rich Interaction Domain 2</td></tr> [@kadoch2015]
<tr><td><strong>Gene Symbol</strong></td><td>ARID2</td></tr> [@hodges2018]
<tr><td><strong>Aliases</strong></td><td>BAF200, p200</td></tr> [@santen2013]
<tr><td><strong>Chromosomal Location</strong></td><td>12q12</td></tr> [@pan2021]
<tr><td><strong>NCBI Gene ID</strong></td><td>[196528](https://www.ncbi.nlm.nih.gov/gene/196528)</td></tr> [@xu2020]
<tr><td><strong>OMIM</strong></td><td>[609539](https://omim.org/entry/609539)</td></tr> [@mao2022]
<tr><td><strong>Ensembl</strong></td><td>[ENSG00000189079](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000189079)</td></tr> [@tsurusaki2012]
<tr><td><strong>UniProt</strong></td><td>[Q68CP9](https://www.uniprot.org/uniprot/Q68CP9)</td></tr>
<tr><td><strong>Protein</strong></td><td>AT-rich interactive domain-containing protein 2</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), Coffin-Siris syndrome, intellectual disability, autism spectrum disorder</td></tr>
</table>
</div>

Overview

...

ARID2 (AT-Rich Interaction Domain 2)

<div class="infobox infobox-gene">
<h3>ARID2</h3>
<table> [@mashtalir2018]
<tr><td><strong>Full Name</strong></td><td>AT-Rich Interaction Domain 2</td></tr> [@kadoch2015]
<tr><td><strong>Gene Symbol</strong></td><td>ARID2</td></tr> [@hodges2018]
<tr><td><strong>Aliases</strong></td><td>BAF200, p200</td></tr> [@santen2013]
<tr><td><strong>Chromosomal Location</strong></td><td>12q12</td></tr> [@pan2021]
<tr><td><strong>NCBI Gene ID</strong></td><td>[196528](https://www.ncbi.nlm.nih.gov/gene/196528)</td></tr> [@xu2020]
<tr><td><strong>OMIM</strong></td><td>[609539](https://omim.org/entry/609539)</td></tr> [@mao2022]
<tr><td><strong>Ensembl</strong></td><td>[ENSG00000189079](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000189079)</td></tr> [@tsurusaki2012]
<tr><td><strong>UniProt</strong></td><td>[Q68CP9](https://www.uniprot.org/uniprot/Q68CP9)</td></tr>
<tr><td><strong>Protein</strong></td><td>AT-rich interactive domain-containing protein 2</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), Coffin-Siris syndrome, intellectual disability, autism spectrum disorder</td></tr>
</table>
</div>

Overview

PBRM1 is a human gene. Variants in PBRM1 have been implicated in Neurodevelopmental Disorders, Alzheimer's Disease, [Parkinson's Disease](/diseases/parkinsons-disease). This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.

Gene Function

ARID2 encodes the BAF200 subunit of the Polybromo-associated BAF (PBAF) chromatin remodeling complex, a variant of the mammalian SWI/SNF complex. ARID2/BAF200 is a defining subunit that distinguishes PBAF from canonical BAF (cBAF) and non-canonical BAF (ncBAF) complexes. ARID2 contains an AT-rich interaction domain (ARID) that binds AT-rich DNA sequences, along with RFX-type winged-helix domains and a C2H2 zinc finger, enabling sequence-specific chromatin targeting.

The PBAF complex uses ATP hydrolysis to remodel nucleosomes, sliding, ejecting, or restructuring histone octamers to regulate transcriptional access. ARID2 plays several critical roles in this process:

Chromatin targeting: The ARID domain of ARID2 recognizes AT-rich DNA sequences prevalent in gene regulatory regions, directing PBAF to specific genomic loci including neural gene enhancers and promoters
Complex assembly: ARID2 serves as a scaffolding subunit that stabilizes PBAF-specific components including [PBRM1](/genes/pbrm1) (polybromo-1/BAF180), [BRD7](/genes/brd7), and PHF10/BAF45a
Enhancer regulation: PBAF is preferentially recruited to super-enhancers and poised enhancers marked by H3K4me1, where it facilitates enhancer activation during neural differentiation
Interferon signaling: ARID2 is required for interferon-stimulated gene (ISG) expression, linking chromatin remodeling to innate immune responses in [microglia](/cell-types/microglia-neuroinflammation) and [astrocytes](/entities/astrocytes)
DNA damage response: PBAF is rapidly recruited to DNA double-strand breaks, where it promotes non-homologous end joining (NHEJ) repair by facilitating access of repair machinery to damaged chromatin

Neural Expression and Brain Distribution

ARID2 is broadly expressed throughout the central nervous system, with particularly high levels in:

Cerebral [cortex](/brain-regions/cortex): Strong expression in pyramidal [neurons](/entities/neurons) across cortical layers, especially in prefrontal and temporal regions critical for cognition
[Hippocampus](/brain-regions/hippocampus): High expression in CA1-CA3 pyramidal neurons and dentate gyrus granule cells, consistent with roles in learning and memory
Cerebellum: Purkinje cells show robust ARID2 expression, reflecting requirements for cerebellar chromatin regulation
Developing brain: Peak expression during embryonic neurogenesis (E12-E18 in mouse), with maintained but reduced adult levels

Single-cell RNA sequencing data show ARID2 expression across all major brain cell types, with highest levels in neurons and oligodendrocyte precursor cells (OPCs).

Disease Associations

Neurodevelopmental Disorders

Heterozygous loss-of-function mutations in ARID2 cause Coffin-Siris syndrome type 6 (CSS6), characterized by intellectual disability, speech delay, coarse facial features, and hypoplastic fifth fingernails. CSS6 phenotypes overlap with those caused by mutations in other SWI/SNF subunits including [ARID1A](/genes/arid1a), [ARID1B](/genes/arid1b), [SMARCA2](/genes/smarca2), [SMARCA4](/genes/smarca4), and [SMARCB1](/genes/smarcb1), establishing SWI/SNF dysfunction as a convergent mechanism in intellectual disability.

Alzheimer's Disease

ARID2 has emerging connections to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis through several mechanisms:

Neuroinflammatory gene regulation: PBAF-dependent chromatin remodeling is required for microglial activation and expression of pro-inflammatory cytokines including [IL-1β](/genes/il1b), [TNF-α](/genes/tnf), and [IL-6](/genes/il6). ARID2 dysfunction may contribute to aberrant neuroinflammatory responses in AD
[Tau](/proteins/tau) pathology: SWI/SNF complexes regulate expression of [MAPT](/genes/mapt) and tau kinases; disrupted PBAF function alters tau phosphorylation cascades
Epigenetic drift: Age-related decline in ARID2 expression correlates with progressive loss of chromatin accessibility at neuroprotective gene loci, potentially accelerating neurodegeneration

Parkinson's Disease

Alpha-synuclein toxicity: PBAF chromatin remodeling protects against [alpha-synuclein](/proteins/alpha-synuclein)-mediated transcriptional dysregulation; ARID2 loss sensitizes dopaminergic neurons to synuclein aggregation
Mitochondrial gene regulation: PBAF regulates nuclear-encoded mitochondrial genes including [PINK1](/genes/pink1) and [PRKN](/genes/prkn); ARID2 dysfunction may impair mitophagy pathways

Cancer

ARID2 is a frequently mutated tumor suppressor in hepatocellular carcinoma, melanoma, and non-small cell lung cancer. Somatic ARID2 mutations are found in ~7% of hepatocellular carcinomas, making it one of the most commonly mutated chromatin regulators in cancer.

Common Variants

| Variant | Type | Population Frequency | Clinical Significance |
|---------|------|---------------------|----------------------|
| p.Gln1334* | Nonsense | Rare | Coffin-Siris syndrome |
| p.Arg1068Cys | Missense | Rare | Likely pathogenic (NDD) |
| rs17208659 | Intronic | 0.08 (global) | AD risk modifier (suggestive) |
| p.Leu735fs | Frameshift | Rare | Coffin-Siris syndrome |

Therapeutic Implications

PBAF-targeted therapies: Small molecules that selectively inhibit PBAF (sparing cBAF and ncBAF) are under development for ARID2-mutant cancers; understanding neural effects is critical for CNS safety assessment
Epigenetic rescue: [HDAC](/entities/hdac-enzymes) inhibitors may partially compensate for PBAF-mediated chromatin accessibility deficits, restoring expression of neuroprotective genes in ARID2-haploinsufficient neurons
Anti-inflammatory strategies: Modulating ARID2-dependent interferon responses in microglia could reduce neuroinflammation in AD and PD without complete immune suppression
Gene therapy: AAV-mediated ARID2 supplementation is theoretically feasible but challenged by the large transcript size (~5.5 kb coding sequence)

External Links

[NCBI Gene: ARID2](https://www.ncbi.nlm.nih.gov/gene/196528)
[GeneCards: ARID2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ARID2)
[OMIM: 609539](https://omim.org/entry/609539)
[UniProt: Q68CP9](https://www.uniprot.org/uniprot/Q68CP9)
[Allen Brain Atlas: ARID2](https://portal.brain-map.org/)

References

[Yan et al., BAF250B/ARID2 and the PBAF chromatin remodeling complex in hepatocellular carcinoma (2014) (2014)](https://doi.org/10.1016/j.jhep.2014.03.024)

[Vasileiou et al., Mutations in the BAF-complex subunit DPF2 are associated with Coffin-Siris syndrome (2018) (2018)](https://doi.org/10.1016/j.ajhg.2018.01.014)

[Mashtalir et al., Modular organization and assembly of SWI/SNF family chromatin remodeling complexes (2018) (2018)](https://doi.org/10.1016/j.cell.2018.09.032)

[Unknown, Kadoch & Crabtree, Mammalian SWI/SNF chromatin remodeling complexes and cancer (2015) (2015)](https://doi.org/10.1016/j.tig.2015.02.005)

[Hodges et al., Dominant-negative SMARCA4 mutants alter chromatin accessibility genome-wide (2018) (2018)](https://doi.org/10.1038/s41588-018-0263-x)

[Santen et al., Coffin-Siris syndrome and the BAF complex: genotype-phenotype study in 63 patients (2013) (2013)](https://doi.org/10.1002/humu.22394)

[Pan et al., PBAF loss alters enhancer chromatin landscape and cell identity during brain development (2021) (2021)](https://doi.org/10.1038/s41593-021-00876-w)

[Xu et al., ARID2 deficiency promotes tumor immune evasion via PBAF-dependent chromatin remodeling (2020) (2020)](https://doi.org/10.1016/j.ccell.2020.04.005)

[Mao et al., SWI/SNF chromatin remodeling complexes in neurodevelopmental and neurodegenerative disorders (2022) (2022)](https://doi.org/10.1016/j.tins.2022.04.002)

[Tsurusaki et al., Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome (2012) (2012)](https://doi.org/10.1038/ng.2219)

📖 View canonical wiki page →

Related Entities

ARID2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-arid2
kg_node_id	ARID2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-1b4e25ff4f76
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-arid2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

27

Outgoing

30

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

ARID2 (AT-Rich Interaction Domain 2)

ARID2 (AT-Rich Interaction Domain 2)

Overview

ARID2 (AT-Rich Interaction Domain 2)

Overview

Gene Function

Neural Expression and Brain Distribution

Disease Associations

Neurodevelopmental Disorders

Alzheimer's Disease

Parkinson's Disease

Cancer

Common Variants

Therapeutic Implications

See Also

External Links

References

💬 Discussion